{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:03:54Z","timestamp":1795136634554,"version":"4.10.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-019-0480-z","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T16:03:38Z","timestamp":1560787418000},"page":"1627-1635","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":176,"title":["Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection"],"prefix":"10.1038","volume":"4","author":[{"given":"Victor I.","family":"Band","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hufnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Jaggavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar X.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie E.","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah W.","family":"Satola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Farley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse T.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Burd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0980-7866","authenticated-orcid":false,"given":"David S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"key":"480_CR1","unstructured":"Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations (Review on Antimicrobial Resistance, 2014); https:\/\/amr-review.org\/Publications.html"},{"key":"480_CR2","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1128\/AAC.01365-09","volume":"54","author":"ST Micek","year":"2010","unstructured":"Micek, S. T. et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob. Agents Chemother. 54, 1742\u20131748 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"480_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1084\/jem.85.6.607","volume":"85","author":"HE Alexander","year":"1947","unstructured":"Alexander, H. E. & Leidy, G. Mode of action of streptomycin on type B Hemophilis influenzae: nature of resistant variants. J. Exp. Med 85, 607\u2013621 (1947).","journal-title":"J. Exp. Med"},{"key":"480_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/AAC.15.1.14","volume":"15","author":"JL Ott","year":"1979","unstructured":"Ott, J. L., Turner, J. R. & Mahoney, D. F. Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae. Antimicrob. Agents Chemother. 15, 14\u201319 (1979).","journal-title":"Antimicrob. Agents Chemother."},{"key":"480_CR5","first-page":"351","volume":"94","author":"P S\u00f8gaard","year":"1986","unstructured":"S\u00f8gaard, P. & Gahrn-Hansen, B. Population analysis of susceptibility to ciprofloxacin and nalidixic acid in Staphylococcus, Pseudomonas aeruginosa, and Enterobacteriaceae. Acta Pathol. Microbiol. Immunol. Scand. B 94, 351\u2013356 (1986).","journal-title":"Acta Pathol. Microbiol. Immunol. Scand. B"},{"key":"480_CR6","doi-asserted-by":"publisher","first-page":"16053","DOI":"10.1038\/nmicrobiol.2016.53","volume":"1","author":"VI Band","year":"2016","unstructured":"Band, V. I. et al. Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae. Nat. Microbiol. 1, 16053 (2016).","journal-title":"Nat. Microbiol"},{"key":"480_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1128\/CMR.00058-14","volume":"28","author":"OM El-Halfawy","year":"2015","unstructured":"El-Halfawy, O. M. & Valvano, M. A. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin. Microbiol. Rev. 28, 191\u2013207 (2015).","journal-title":"Clin. Microbiol. Rev."},{"key":"480_CR8","unstructured":"Antibiotic Resistance Threats in the United States, 2013 (US CDC, 2013)."},{"key":"480_CR9","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/jama.2015.12480","volume":"314","author":"AY Guh","year":"2015","unstructured":"Guh, A. Y. et al. Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012\u20132013. JAMA 314, 1479\u20131487 (2015).","journal-title":"JAMA"},{"key":"480_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.15585\/mmwr.mm6601a7","volume":"66","author":"L Chen","year":"2016","unstructured":"Chen, L., Todd, R., Kiehlbauch, J., Walters, M. & Kallen, A. Pan-resistant New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae \u2014 Washoe County, Nevada, 2016. Morb. Mortal. Wkly Rep. 66, 33 (2016).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"480_CR11","unstructured":"Multi-site Gram-negative Surveillance Initiative (US CDC, 2016)."},{"key":"480_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","volume":"14","author":"A Brauner","year":"2016","unstructured":"Brauner, A., Fridman, O., Gefen, O. & Balaban, N. Q. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat. Rev. Microbiol. 14, 320\u2013330 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"480_CR13","doi-asserted-by":"publisher","first-page":"e00100","DOI":"10.1128\/mBio.00100-11","volume":"2","author":"I Keren","year":"2011","unstructured":"Keren, I., Minami, S., Rubin, E. & Lewis, K. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio 2, e00100\u2013e00111 (2011).","journal-title":"mBio"},{"key":"480_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.1229858","volume":"339","author":"Y Wakamoto","year":"2013","unstructured":"Wakamoto, Y. et al. Dynamic persistence of antibiotic-stressed mycobacteria. Science 339, 91\u201395 (2013).","journal-title":"Science"},{"key":"480_CR15","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1128\/AAC.02432-14","volume":"58","author":"BA Napier","year":"2014","unstructured":"Napier, B. A., Band, V., Burd, E. M. & Weiss, D. S. Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme. Antimicrob. Agents Chemother. 58, 5594\u20135597 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"480_CR16","doi-asserted-by":"publisher","unstructured":"Kang K. N. et al. Colistin heteroresistance in Enterobacter cloacae is regulated by PhoPQ-dependent 4-amino-4-deoxy-l-arabinose addition to lipid A. Mol. Microbiol. https:\/\/doi.org\/10.1111\/mmi.14240 (2019).","DOI":"10.1111\/mmi.14240"},{"key":"480_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jmii.2017.10.006","volume":"52","author":"TY Yang","year":"2017","unstructured":"Yang, T. Y., Lu, P. L. & Tseng, S. P. Update on fosfomycin-modified genes in Enterobacteriaceae. J. Microbiol. Immunol. Infect. 52, 9\u201321 (2017).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"480_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/mdr.1995.1.111","volume":"1","author":"S Normark","year":"1995","unstructured":"Normark, S. Beta-lactamase induction in Gram-negative bacteria is intimately linked to peptidoglycan recycling. Microb. Drug Resist. 1, 111\u2013114 (1995).","journal-title":"Microb. Drug Resist."},{"key":"480_CR19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41564-018-0342-0","volume":"4","author":"H Nicoloff","year":"2019","unstructured":"Nicoloff, H., Hjort, K., Levin, B. R. & Andersson, D. I. The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nat. Microbiol. 4, 504\u2013514 (2019).","journal-title":"Nat. Microbiol."},{"key":"480_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cmi.2016.12.022","volume":"23","author":"M Ballestero-T\u00e9llez","year":"2017","unstructured":"Ballestero-T\u00e9llez, M. et al. Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae. Clin. Microbiol. Infect. 23, 325\u2013331 (2017).","journal-title":"Clin. Microbiol. Infect."},{"key":"480_CR21","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","volume":"328","author":"M Paul","year":"2004","unstructured":"Paul, M., Benuri-Silbiger, I., Soares-Weiser, K. & Leibovici, L. Beta lactam monotherapy versus beta lactam\u2013aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328, 668 (2004).","journal-title":"BMJ"},{"key":"480_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/AAC.41.5.1127","volume":"41","author":"L Leibovici","year":"1997","unstructured":"Leibovici, L. et al. Monotherapy versus beta-lactam\u2013aminoglycoside combination treatment for Gram-negative bacteremia: a prospective, observational study. Antimicrob. Agents Chemother. 41, 1127\u20131133 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"480_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1201-9712(98)90055-8","volume":"2","author":"Y Siegman-Igra","year":"1998","unstructured":"Siegman-Igra, Y., Ravona, R., Primerman, H. & Giladi, M. Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy. Int. J. Infect. Dis. 2, 211\u2013215 (1998).","journal-title":"Int. J. Infect. Dis."},{"key":"480_CR24","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/archsurg.134.12.1293","volume":"134","author":"TD Crabtree","year":"1999","unstructured":"Crabtree, T. D., Pelletier, S. J., Gleason, T. G., Pruett, T. L. & Sawyer, R. G. Analysis of aminoglycosides in the treatment of Gram-negative infections in surgical patients. Arch. Surg. 134, 1293\u20131299 (1999).","journal-title":"Arch. Surg."},{"key":"480_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/00003246-200202000-00017","volume":"30","author":"P Montravers","year":"2002","unstructured":"Montravers, P. et al. Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: results of the Eole study. Crit. Care Med. 30, 368\u2013375 (2002).","journal-title":"Crit. Care Med."},{"key":"480_CR26","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1177\/106002809002401215","volume":"24","author":"TH Grasela","year":"1990","unstructured":"Grasela, T. H. et al. A nationwide survey of antibiotic prescribing patterns and clinical outcomes in patients with bacterial pneumonia. DICP 24, 1220\u20131225 (1990).","journal-title":"DICP"},{"key":"480_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds, F. C. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52, 1 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"480_CR28","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1128\/JCM.01121-14","volume":"52","author":"CD Doern","year":"2014","unstructured":"Doern, C. D. When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J. Clin. Microbiol. 52, 4124\u20134128 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"480_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/CMR.05041-11","volume":"25","author":"PD Tamma","year":"2012","unstructured":"Tamma, P. D., Cosgrove, S. E. & Maragakis, L. L. Combination therapy for treatment of infections with Gram-negative bacteria. Clin. Microbiol. Rev. 25, 450\u2013470 (2012).","journal-title":"Clin. Microbiol. Rev."},{"key":"480_CR30","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/jac\/dku168","volume":"69","author":"M Paul","year":"2014","unstructured":"Paul, M. et al. Combination therapy for carbapenem-resistant Gram-negative bacteria. J. Antimicrob. Chemother. 69, 2305\u20132309 (2014).","journal-title":"J. Antimicrob. Chemother."},{"key":"480_CR31","unstructured":"Etest application guide (bioM\u00e9rieux, 2012); https:\/\/go.nature.com\/2WavcTf"},{"key":"480_CR32","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1073\/pnas.120163297","volume":"97","author":"KA Datsenko","year":"2000","unstructured":"Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 6640\u20136645 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0480-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0480-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0480-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T03:46:13Z","timestamp":1671248773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0480-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["480"],"URL":"https:\/\/doi.org\/10.1038\/s41564-019-0480-z","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]},"assertion":[{"value":"28 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.I.B., D.A.H. and D.S.W. are listed authors on a provisional patent that has been filed related to the work described here.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}